Balanced news tone
News Sentiment
AUROPHARMA sentiment intelligence
Aurobindo Pharma Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
85/100 classification confidence.
directly relevant articles
high-authority source matches
-3.4% over one week, +6.2% over four weeks, trend active, and materially above fair value.
Stock Picks Today: DMart, L&T Finance, LTM, CarTrade, Aurobindo Pharma, And More On Brokerages' Radar
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Investing in Aurobindo Pharma (NSE:AUROPHARMA) three years ago would have delivered you a 167% gain
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jan 2026 08:00
- Source
- simplywall.st
Aurobindo Pharma Limited (NSE:AUROPHARMA) Shares Could Be 27% Above Their Intrinsic Value Estimate
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Dec 2025 08:00
- Source
- simplywall.st
Investors Don't See Light At End Of Aurobindo Pharma Limited's (NSE:AUROPHARMA) Tunnel
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Nov 2025 08:00
- Source
- simplywall.st
We Discuss Whether Aurobindo Pharma Limited's (NSE:AUROPHARMA) CEO Is Due For A Pay Rise
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Sep 2025 07:00
- Source
- simplywall.st
Here's Why We Think Aurobindo Pharma (NSE:AUROPHARMA) Might Deserve Your Attention Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2025 07:00
- Source
- simplywall.st